Private Advisor Group, LLC Soligenix, Inc. Transaction History

Private Advisor Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 13, 2019	SELL	$0.88 - $1.04 $17,864 - $21,112	-20,300 Closed	0 $0
Q4 2018 Feb 11, 2019	BUY	$0.85 - $2.1 $255 - $630	300 Added 1.5%	20,300 $17,000
Q3 2018 Nov 01, 2018	BUY	$0.98 - $1.97 $19,600 - $39,400	20,000 New	20,000 $38,000
Q1 2018 May 09, 2018	SELL	$1.92 - $2.4 $49,920 - $62,400	-26,000 Closed	0 $0
Q4 2017 Feb 07, 2018	BUY	$1.84 - $2.32 $47,840 - $60,319	26,000	26,000 $59,000

Ticker SNGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,105,200
Market Cap $151M
Description
Soligenix, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing products to treat rare diseases in the United States. It operates in two segments, Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics segment develops SGX301 (HyBryte), a novel photodynamic therapy, which has c...

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Private Advisor Group, LLC with notifications on news.